C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/635 (2006.01) A61K 38/29 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2327509
This invention relates to a series of PTH and PTHrP analogues that selectively bind to PTH2 receptors and as such may be useful in treating abnormal CNS functions; abnormal pancreatic functions; divergence from normal mineral metabolism and homeostasis; male infertility; regulation of abnormal blood pressure; and hypothalmic disease.
Cette invention porte sur une série d'analogues PTH et PTHrP qui se lient sélectivement aux récepteurs PTH2 et qui, de ce fait, peuvent être utiles dans le traitement des fonctions anormales du système nerveux central, des fonctions pancréatiques anormales, des divergences provenant du métabolisme minéral normal et de l'homéostasie, de la stérilité masculine, de la régulation de la pression sanguine anormale et des maladies de la région hypothalamique.
Chorev Michael
Dong Zheng Xin
Rosenblatt Michael
Beth Israel Deaconess Medical Center Inc.
Ipsen Pharma S.a.s
Smart & Biggar
Societe de Conseils de Recherches Et D'applications Scientifique
LandOfFree
Pth2 receptor selective compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pth2 receptor selective compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pth2 receptor selective compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1557723